O-GlcNAcylation of fumarase maintains tumour growth under glucose deficiency

Ting Wang1,2, Qiujing Yu1, Jingjie Li1

  • 1The Institute of Cell Metabolism, Shanghai Key Laboratory of Pancreatic Disease, Shanghai General Hospital, Shanghai Jiaotong University, School of Medicine, Shanghai 200080, China.

Nature Cell Biology
|June 20, 2017
PubMed

Insights

Chromatin-associated fumarase (FH) regulates gene transcription by influencing histone methylation under glucose deprivation. Dysregulated O-GlcNAcylation of FH, particularly in cancer cells, impedes this process, correlating with poor prognosis.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Cancer Biology

Background:

  • Chromatin-associated fumarase (FH) impacts histone methylation through its metabolic functions.
  • The precise role of FH in gene transcription regulation requires further elucidation.

Purpose of the Study:

  • To investigate the mechanism by which FH influences gene transcription under glucose deprivation.
  • To explore the interplay between FH phosphorylation, O-GlcNAcylation, and cancer cell growth.

Main Methods:

  • Investigated the interaction between AMPK, FH, and ATF2 under glucose-limited conditions.
  • Assessed the impact of FH-catalyzed fumarate on KDM2A demethylase activity and H3K36me2 levels.
  • Analyzed FH O-GlcNAcylation and its effect on FH-ATF2 complex formation.
  • Correlated FH phosphorylation and O-GlcNAcylation levels with OGT activity and patient prognosis in pancreatic cancer.

Main Results:

  • AMP-activated protein kinase (AMPK) phosphorylates FH at Ser75 under glucose deprivation, promoting promoter activation via an FH-ATF2 complex.
  • FH-derived fumarate inhibits KDM2A, maintaining H3K36me2 and facilitating gene expression for cell growth arrest.
  • FH O-GlcNAcylation at Ser75 impedes FH-ATF2 complex formation and downstream transcriptional regulation, especially in cancer cells with high O-GlcNAc transferase (OGT) activity.
  • FH-Ser75 phosphorylation inversely correlates with OGT levels and predicts poor prognosis in pancreatic cancer.

Conclusions:

  • Uncovered a novel mechanism of transcriptional regulation by FH involving its metabolic activity and post-translational modifications.
  • Demonstrated a link between dysregulated OGT activity, FH modification, and cancer cell proliferation advantage under nutrient stress.
  • FH phosphorylation and O-GlcNAcylation represent potential therapeutic targets in cancer treatment.

Related Concept Videos

Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
7.2K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.9K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.3K
Glucose Transporters01:27

Glucose Transporters

Glucose transporters facilitate the transport of glucose across the cell membrane. In addition to glucose, some glucose transporters can also aid the movement of other hexoses such as fructose, mannose, and galactose.
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
27.8K
Oligosaccharide Assembly01:24

Oligosaccharide Assembly

Protein glycosylation starts in the ER lumen and continues in the Golgi apparatus. Glycosyltransferases catalyze the addition of sugar molecules or glycosylation of proteins. Usually, these enzymes add sugars to the hydroxyl groups of selected serine or threonine residues to form O-linked glycans or the amino groups of asparagine residues to form N-linked glycans. Different positions on the same polypeptide chain can contain differently linked glycans.
Multiple sugar molecules that may or may...
3.8K
Glucose Homeostasis: Regulation of Blood Glucose01:02

Glucose Homeostasis: Regulation of Blood Glucose

Carbohydrates consumed through foods are converted into glucose, a crucial energy source for the body. In the prandial state, high blood glucose levels stimulate the secretion of insulin from the pancreas. Insulin inhibits hepatic glucose production and stimulates glucose uptake and metabolism by muscle and adipose tissue. The excess glucose is converted into glycogen and stored in the liver and muscles.
During fasting, when blood glucose levels are low, the pancreas secretes glucagon. it...
4.7K